Combined BRAF (Dabrafenib) and MEK Inhibition (Trametinib) in Patients With BRAFV600-Mutant Melanoma Experiencing Progression With Single-Agent BRAF …

DB Johnson, KT Flaherty, JS Weber… - Journal of Clinical …, 2014 - ascopubs.org
combined BRAF and MEK inhibition is more effective in BRAF V600 -mutant melanoma than
single-agent BRAF inhibitors. … in patients who had received prior BRAF inhibitor treatment. …

Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma

AW Tolcher, A Patnaik, KP Papadopoulos… - Cancer chemotherapy …, 2015 - Springer
… of one such combination, trametinib (MEK inhibitor) with afuresertib (AKT inhibitor). … events
and pneumonitis (all considered class effect with MEK inhibitors) [13] and GI-related events (…

Dual Inhibition of PI3K-AKT-mTOR-and RAF-MEK-ERK-signaling is synergistic in cholangiocarcinoma and reverses acquired resistance to MEK-inhibitors

F Ewald, D Nörz, A Grottke, BT Hofmann… - Investigational new …, 2014 - Springer
combining AZD6244 with mTOR inhibitor AZD8055 should be similarly synergistic to combining
AKT and MEK inhibition… the CCA cells lines after combined treatment with AZD6244 and …

MEK inhibitors in oncology: A patent review (2015-Present)

DK Mahapatra, V Asati, SK Bharti - Expert Opinion on Therapeutic …, 2017 - Taylor & Francis
… The MEK inhibitors in combination with other kinase/mutant gene inhibitors have shown …
Various researches have shown that ERK inhibitors in combination with MEK inhibitors

Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAFV600E-Mutant Colorectal Cancer

RB Corcoran, T André, CE Atreya, JHM Schellens… - Cancer discovery, 2018 - AACR
inhibitor, may optimize MAPK pathway suppression and … of combined BRAF and EGFR
inhibition, combined MEK and EGFR inhibition, and combined BRAF, EGFR, and MEK inhibition

Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma

A Ribas, D Lawrence, V Atkinson, S Agarwal… - Nature medicine, 2019 - nature.com
… of a concomitant triple-therapy combination of BRAF and MEK inhibitors with anti-PD-1 in …
1 trial, a combination of approved doses of the BRAF inhibitor dabrafenib, the MEK inhibitor

[HTML][HTML] BRAF mutations and the utility of RAF and MEK inhibitors in primary brain tumors

KC Schreck, SA Grossman, CA Pratilas - Cancers, 2019 - mdpi.com
… with RAF and MEK inhibitors in patients with primary brain tumors and describe ongoing
clinical trials of RAF inhibitors in … this, RAF inhibitors have been combined with MEK inhibitors in …

Molecular Pathways: The Basis for Rational Combination Using MEK Inhibitors in KRAS-Mutant Cancers

S Okumura, PA Jänne - Clinical cancer research, 2014 - AACR
… Moreover, MEK inhibitors can arrest cancer cells in G 1 phase and repress prosurvival Bcl2
… of the combination of MEK inhibitors with cytotoxic agents or other targeted inhibitors. A …

[HTML][HTML] Combined targeting of Raf and Mek synergistically inhibits tumorigenesis in triple negative breast cancer model systems

TS Nagaria, C Shi, C Leduc, V Hoskin, S Sikdar… - Oncotarget, 2017 - ncbi.nlm.nih.gov
… We next explored combined Raf and Mek inhibition using SFN and AZD6244 in a mouse
orthotopic xenograft model. MDA-MB-231 cells were engrafted into mammary glands of BALB/c …

[HTML][HTML] Combination of a selective HSP90α/β inhibitor and a RAS-RAF-MEK-ERK signaling pathway inhibitor triggers synergistic cytotoxicity in multiple myeloma cells

R Suzuki, S Kikuchi, T Harada, N Mimura, J Minami… - PloS one, 2015 - journals.plos.org
… novel combination treatment with HSP90α/β inhibitor and RAS-RAF-MEK-ERK signaling
pathway inhibitors … that the combination of RAF inhibitors and MEK inhibitors shows significant …